[Welcome to the 20th National Congress of the Party] Zibo joint academicians and academicians have been in terms of major innovative medicines

The hot soil of Zibo is as hot as the sun at noon.

On June 19, Xinhua Pharmaceutical held a grand ceremony, and Yang Baofeng, an academician of the Chinese Academy of Engineering, was appointed as the company's "chief scientist of major innovative drugs". It was even more shaken that the two sides would work together to the design and discovery of major innovative drugs.

Looking back at history, Zibo is a city with deep origin with medicine. Xinhua Pharmaceutical developed from the Jiaodong Anti -Line in 1943. Focusing on reality, Zibo is a fertile soil in which inherited pharmaceutical genes and implemented a new pharmaceutical climbing plan, which has attracted more and more. The more medicine, the "big coffee" in Zibo.

This time I chose Zibo's "big coffee" to be Yang Baofeng.

Academician Yang Baofeng was the president of Harbin Medical University. He is currently an academician of the Chinese Academy of Engineering, a member of the Royal Biology Society of the United Kingdom, a member of the Chinese Academy of Medical Sciences, and a honorary chairman of the China Cardiovascular Pharmacology Committee. The leaders of the national key discipline, national teaching team and national scientific and technological innovation group have won the honorary titles such as the National Innovation Prize, the second prize of the National Natural Science Science, and the first top ten national outstanding science and technology workers.

He has been engaged in the study of cardiovascular and cerebrovascular diseases for nearly 40 years and has been in the international leading level in the field of major heart disease (myocardial ischemia/arrhythmia/cardiac failure). The target theory of ion channels with drug effects has published more than 300 papers in international famous journals such as Nature Medicine. He hosted a variety of new drugs such as Daming Capsules, Kanglexin Capsules, and Plastic Plaza, which has achieved significant economic and social benefits.

After being hired as the "chief scientist of major innovation drugs" in Xinhua Pharmaceuticals, Academician Yang Baofeng and his team will jointly build Xinhua Pharmaceutical Cardiovascular and Cerebral Vascular New drug innovation teams and discovery platforms, design and discover major new drugs, and actively participate in major national innovation projects Studies, explore the construction of the "major innovative drug discovery and evaluation" joint laboratory, especially in the fields of anti -heart failure, antiplication hardening, venous occlusion, anti -lung fibrosis and other fields. Effective drugs, at the same time, carry out joint research on major common technologies, and actively participate in research on major national innovation topics.

"On this basis, the two parties will further strengthen high -level academic exchanges, promote the joint training of high -level pharmaceutical talents, promote Xinhua Pharmaceutical's scientific and technological innovation and research and development capabilities in the field of cardiovascular and cerebrovascular, and enhance overall strength and overall strength and overall strength and overall strength and overall strength and The level has laid a solid foundation for the launch of more major innovative drugs. "Zhang Daiming, chairman of Xinhua Pharmaceutical and Party Committee, told reporters.

At the appointment ceremony, Zhang Daiming introduced the development of Xinhua Pharmaceutical's development, development strategy, scientific research innovation, and talent construction. After listening, Academician Yang Baofeng said that through the field visiting Xinhua Pharmaceutical Exhibition Hall, R & D Center, and International Cooperation Center of Modern Pharmaceuticals, he had a deeper understanding of Xinhua Pharmaceutical, and made outstanding contributions to the development of Xinhua National Pharmaceuticals, as well as the times with the times. The development of the development and adherence to scientific and technological innovation expressed admiration, and was very happy to accept the appointment of Xinhua Pharmaceutical. It was willing to help the innovation and development of Xinhua Pharmaceutical in the research and development of new cardiovascular and cerebrovascular drugs.

Summer Zibo, vitality. Choosing Zibo and choosing Xinhua Pharmaceutical is to choose opportunities. The dream of enterprises with a high level of wisdom and bigger and stronger is taking root in this fertile soil, and the beautiful prospects of Zibo's new pharmaceutical industry are becoming more and more clear. (Reporter Sha Hongcui Correspondent Wu Yanhua)

- END -